EFFECTS OF KSR ON PATENT PRACTICE

Similar documents
DING DONG, THE RULES ARE DEAD!* AND OTHER UPDATES ON US PATENT LAW

Winning a Non-Obviousness Case at the Board

Strategies... to Prepare for an Interference Washington, D.C. 17 October 2002

The New PTO Patent Rules Published 6/30/2003. Arlington VA August, 2003

KSR INTERNATIONAL CO. v. TELEFLEX INC.: Analysis and Potential Impact for Patentees

OLIVE & OLIVE, P.A. INTELLECTUAL PROPERTY LAW

Duh! Finding the Obvious in a Patent Application

The Serious Burden Requirement Has Teeth - A Prohibition on Restriction Requirements Later in Prosecution

2010 KSR Guidelines Update, 75 FR (September 1, 2010) Updated PTO guidelines on obviousness determinations in a post KSR World

New Patent Application Rules Set to Take Effect November 1, 2007

Patent Prosecution in View of The America Invents Act. Overview

Royal Society of Chemistry Law Group. Recent Case Law Relevant to Chemistry

IP CONCLAVE 2010, MUMBAI STRATEGIES WITH US PATENT PRACTICE NAREN THAPPETA US PATENT ATTORNEY & INDIA PATENT AGENT BANGALORE, INDIA

Changes To Implement the First Inventor To File Provisions of the Leahy-Smith America Invents Act Final Rules

America Invents Act: Patent Reform

Newly Signed U.S. Patent Law Will Overhaul Patent Procurement, Enforcement and Defense

Patent Prosecution Update

Can I Challenge My Competitor s Patent?

Paper Entered: January 11, 2016 UNITED STATES PATENT AND TRADEMARK OFFICE BEFORE THE PATENT TRIAL AND APPEAL BOARD

KSR International Co., v. Teleflex Inc. U.S. Supreme Court, April 2007

UPDATES ON US PATENT LAW AND PRACTICE

Patent Resources Group. Chemical Patent Practice. Course Syllabus

Inventive Step. Japan Patent Office

Accelerated Examination. Presented by Hans Troesch, Principal Fish & Richardson P.C. March 2, 2010

Patent Practice in View Of PTAB AIA Proceedings

America Invents Act: Patent Reform

Chemical Patent Practice. Course Syllabus

The patentability criteria for inventive step I nonobviousness. The Groups are invited to answer the following questions under their national laws:

AIA Post-Grant Proceedings: Lessons Learned from PTAB and Federal Circuit Decisions

The Patentability Search

USPTO Trials: Understanding the Scope and Rules of Discovery

The Changing Face of U.S. Patent Litigation

America Invents Act (AIA) Post-Grant Proceedings

America Invents Act: The Practical Effects of the New USPTO Post-Grant Proceedings

America Invents Act H.R (Became Law: September 16, 2011) Michael K. Mutter Birch, Stewart, Kolasch & Birch October 11-12, 2011

CBM Eligibility and Reviewability

AIA Post-Grant Implementation Begins - Is Your Business Strategy Aligned? August 27, A Web conference hosted by Foley & Lardner LLP

Working Guidelines Q217. The patentability criteria for inventive step / non-obviousness

Brad R. Maurer and Louis T. Perry Abigail M. Butler.

Correction of Patents

USPTO Final Rule Changes for Continuations and Claims. John B. Pegram Ronald C. Lundquist August 30, 2007

In the Wake of KSR: Sea Change or Wait-and-See?

KSR. Managing Intellectual Property May 30, Rick Frenkel Cisco Systems Kevin Rhodes 3M Kathi Kelly Lutton F&R John Dragseth F&R

The America Invents Act : What You Need to Know. September 28, 2011

PATENTS TRADEMARKS COPYRIGHTS TRADE SECRETS ZIOLKOWSKI PATENT SOLUTIONS GROUP, SC INTELLECTUAL PROPERTY ATTORNEYS. Patent Process FAQs

Strategic Use of Post-Grant Proceedings In Light of Patent Reform

Five Winning Strategies for Crafting Claims in U.S. Patent Applications

The Patent Bar's Role In Setting PTAB Precedence

UNITED STATES PATENT AND TRADEMARK OFFICE. REPORT TO CONGRESS on INTER PARTES REEXAMINATION. Executive Summary

COMPARATIVE STUDY REPORT TRILATERAL PROJECT 12.4 INVENTIVE STEP - 1 -

The America Invents Act, Its Unique First-to-File System and Its Transfer of Power from Juries to the United States Patent and Trademark Office

(Serial No. 29/253,172) IN RE TIMOTHY S. OWENS, SHEILA M. KELLY, ROBERT M. LYNCH, IV, JASON C. CAMPBELL, and PHILIP E.

Considerations for the United States

Policies of USPTO Director Kappos & U.S. Patent Law Reform

2011 Foley & Lardner LLP Attorney Advertising Prior results do not guarantee a similar outcome Models used are not clients but may be representative

New Rules: USPTO May Have Underestimated Impact

COMPARATIVE STUDY REPORT INVENTIVE STEP (JPO - KIPO - SIPO)

Sophisticated Use of Reexamination and Reissue. Robert M. Asher Bromberg & Sunstein, LLP AIPLA Advanced Patent Prosecution Seminar 2005

EFFECTIVE DATES OF THE VARIOUS RULES AND REQUIREMENTS

United States. Edwards Wildman. Author Daniel Fiorello

Paper Entered: April 21, 2015 UNITED STATES PATENT AND TRADEMARK OFFICE BEFORE THE PATENT TRIAL AND APPEAL BOARD

Inventive Step in Japan Masashi Moriwaki

Pre-Issuance Submissions under the America Invents Act

KSR International Co. v. Teleflex Inc.: Patentability Clarity or Confusion?

Will the Board of Patent Appeals and Interferences Rely Upon Dictionary Definitions Newly. Cited in Appeal Briefs? Answer: It Depends

Patent Exam Fall 2015

Lessons From IPRs Involving Agriculture-Related Patents

IN THE UNITED STATES DISTRICT COURT FOR THE EASTERN DISTRICT OF TEXAS MARSHALL DIVISION

United States Court of Appeals for the Federal Circuit

The use of prosecution history in post-grant patent proceedings

Are all pending claims now indefinite? Robert A. Schwartzman, Ph.D.

Patent Resources Group Federal Circuit Law Course Syllabus

IP Innovations Class

Patent Reform Act of 2007

AMERICA INVENTS ACT. Changes to Patent Law. Devan Padmanabhan Shareholder, Winthrop & Weinstine

JETRO seminar. Recent Rule change and latest developments at the EPO:

Brief Summary of Precedential Patent Case Law For the Period to

New Post Grant Proceedings: Basics by

Post-Grant for Practitioners

Patent Prosecution Under The AIA

USPTO Implementation of the America Invents Act. Janet Gongola Patent Reform Coordinator Direct dial:

PATENT DISCLOSURE: Meeting Expectations in the USPTO

America Invents Act (AIA) The Patent Reform Law of 2011 Initial Summary

Inventive Step and Non-obviousness: Global Perspectives

Impact of the Patent Reform Bill

COMMERCIAL EVALUATION LICENSE AGREEMENT PURDUE RESEARCH FOUNDATION [ ] PRF Docket No.:

Examination Guidelines for Patentability - Novelty and Inventive Step. Shunsuke YAMAMOTO Examination Standards Office Japan Patent Office 2016.

BCLT Back to School: The New Patent Law Explained (Post-Grant Procedures) Stuart P. Meyer

The New Post-AIA World

America Invents Act of 2011 Part 1: Impact on Litigation Strategy Part 2: Strategic Considerations of the FTF Transition

Petitions and Appeals in the USPTO

U.S. Patent Law Reform The America Invents Act

K&L Gates Webinar Current Developments in Patents. Peggy Focarino Commissioner for Patents September 13 th, 2012

Normal Examination Speed (2/2)

PATENT LAW DEVELOPMENTS

Attachment: Opinions on the Draft Amendment of the Implementing Regulations of the Patent Law of the People s Republic of China

Paper: Entered: January 16, 2018 UNITED STATES PATENT AND TRADEMARK OFFICE BEFORE THE PATENT TRIAL AND APPEAL BOARD

2013 International Series Korea U.S. IP Judicial Conference. Patentability of Chemical/Pharmaceutical Inventions. Isomers/Enantiomers

Doctrine of Equivalents: Recent Developments in Germany

Amendments in Europe and the United States

Transcription:

EFFECTS OF KSR ON PATENT PRACTICE FOR: PIUG (New Brunswick, NJ, October 9, 2007) RICHARD NEIFELD, Ph.D., PATENT ATTORNEY NEIFELD IP LAW, PC - www.neifeld.com EMAIL: rneifeld@neifeld.com 4813-B EISENHOWER AVE., ALEXANDRIA, VA 22304 1

ACTUAL EXAMPLES THESE ARE REAL EXAMPLES FROM MY PERSONAL EXPERIENCE 2

CLIENT CONFIDENCES EXAMPLES ARE DE - IDENTIFIED TO PROTECT CLIENT CONFIDENCES 3

KSR BPAI PRECEDENTIAL CASES FOLLOWING KSR EX PARTE KUBIN BIOTECH. EX PARTE SMITH - MECH. EX PARTE CATAN ELECT. SEE http://www.uspto.gov/web/ offices/dcom/bpai/prec.htm 4

OUTLINE I. EX. 1 THE DING LETTER II. EX. 2 NEW INVENTIONS III. EX. 3 - PROSECUTION IV. CONCLUSIONS 5

EX. 1 SUMMARY IN VIEW OF KSR, PREDICTION OF ULTIMATE USPTO REJECTION OF APPLICATION ASSERTED AGAINST CLIENT... SEARCHER TWIST 6

CLIENT CONFIDENCES CLIENT NOT IDENTIFIED SUBJECT APPLICATION NOT OWNED BY CLIENT 7

EX. 1 - DING! CLIENT RECEIVED DING LETTER PATENT TO ISSUE FROM 10/946,947 ENTITLED "A SYSTEM AND METHOD FOR LEVERAGING HEALTH CARE AT A POINT OF SALE" 8

IDENTIFICATION PROBLEM 10/946,947 UNPUBLISHED 10/946,947 STATUS COULD NOT READILY BE DETERMINED 9

FOREIGN FILING WO 2006/036712 (PCT/US2005/033888) CLAIMS PRIORITY TO 10/946,947 10

VALIDITY ISSUE F.F. IN AN APPLICATION HAVING A NON PUBLICATION REQUEST IS ILLEGAL WAS 10/946,947 ILLEGAL AND THEREFORE ABANDONED? SEE 35 USC 122(2)(B)(iii). 11

VALIDITY ISSUE NO! OIPE OF USPTO FINALLY INDICATED THAT 10/946,947 ABANDONED BEFORE COMPLETION OF APP. ABANDONED APPS. NOT PUBLISHED. 35 USC 122(B)(2)(A)(I). 12

DING LETTER IN ERROR? WHY DID WE GET A DING LETTER BASED UPON AN ABANDONED APPLICATION? 13

DING LETTER IN ERROR? PRESUMED CLERICAL ERROR, LISTING WRONG CASE IN A PATENT FAMILY, ON PART OF ACCUSING PARTY LOOKED FOR RELATED CASES (SAME INVENTOR) 14

RELATED CASES 60/668,886 PROV. 10/946,947 ABAND. 11/370,526 PEND. 09/981,516 PEND. 15

RELATED CASES IN PENDING RELATED CASES, ANALYZED PATENTABILITY OF DISCLOSED CLAIMABLE SUBJECT MATTER IN VIEW OF CATAN/KSR 16

ANALYSIS EXAMPLE 1. A system for generating intelligent promotional recommendations for a product, comprising: a) a database... b) a recommendation engine,...c) a user interface... KNOW TO BE ANTICIPATED 17

ANALYSIS EXAMPLE 7. The system... wherein the user interface comprises a personal digital assistant. CATAN: Substituting bioauthentification sensor for some other authentifier, not patentable. 18

CONSEQUENCES QUICKLY DETERMINED THAT CLAIMABLE SUBJECT MATTER NOT PATENTABLE CLIENT COULD SAFELY IGNORE THE DING LETTER 19

EX. 2 NEW INVENTIONS HOW TO DRAFT APPLICATIONS FOR NEW INVENTIONS IN VIEW OF KSR (AND OTHER CHANGES IN LAW AND PRACTICE) 20

CLIENT CONFIDENCES CLIENT NOT IDENTIFIED SPECIFICS OF INVENTIONS NOT IDENTIFIED 21

THE LAW EX PARTE SMITH The operative question in this functional approach is thus whether the improvement is more than the predictable use of prior art elements according to their established functions. 22

THE NEW RULES NEW USPTO RULES LIMIT THE SIZE OF APPLICATIONS, MAKING IT ADVISABLE TO FILE SMALLER APPLICATIONS 23

EX. 2 FACTS BIOMEDICAL ARTS INVENTIONS ARE SPECIES 1-4 1-4 MANUFACTURES, NOT CHEMICALS, 1-4 SAME GENERIC STRUCTURE, AND FOR SAME PURPOSE ONE PRIOR ART SPECIES, 5 24

EX. 2 FACTS SIMILAR ELEMENTS TO THOSE OF SPECIES 1-4 APPEAR IN PRIOR ART SPECIES 5 25

EX. 2 FACTS SPECIES 1 HAS A SPECIAL UTILITY IN A SPECIAL ENVIRONMENT SPECIAL UTILITY UNKOWN IN THE ART SPECIES 2-5 DO NOT HAVE THE SPECIAL UTILITY 26

KSR RISK 1-4 MIGHT BE REJECTED ON THE THEORY THAT THEY MERELY DEFINE STRUCTURES THAT HAVE A predictable use of prior art elements according to their established functions 27

KSR RISK REJECTION EASY TO REBUT FOR 1 REJECTION MORE DIFFICULT TO REBUT FOR 2-4 28

STRATEGY FOR 1 FILE AN APPLICATION DISCLOSING ONLY SPECIES 1, AND CLAIMING ONLY SPECIES 1 29

BENEFITS AVOID LARGE APPLICATION TRAPS OF 1.75, 1.78(d) AND 1.78(f) AVOIDS CONFUSION OF PATENTABILITY ISSUES WITH 2-4 AVOIDS ESTOPPELS 30

TACTICS FOR 1 DO NOT EXPRESSLY DISCUSS THE SPECIAL UTILTIY OR ENVIRONMNET IN THE APPLICATION ANTICIPATE REJECTION OF SPECIES 1 OVER PRIOR ART SPECIES 5 31

TACTICS USING KSR ANTICIPATED REJECTION SPECIES 1 IS ONLY A predictable use of prior art elements according to their established functions IN VIEW OF SPECIE 5 32

TACTICS USING KSR ANTICIPATED RESPONSE SPECIES 1 YIELDS MORE THAN predictable RESULTS; MORE THAN established functions, IN SPECIAL ENVIRONMENT 33

TACTICS USING KSR ANTICIPATED RESPONSE advance [ would not have] occur[ed], BECAUSE NO ON RECOGNIZED THE SPECIAL UTILITY IN THE SPECIAL ENVIRONMENT 34

CONSEQUENCES OF STRATEGY AND TACTICS FOR SPECIES 1 CLEAN PROSECUTION NO ESTOPPELS ENFORCEABLE PATENT 35

EX. 2 SUMMARY KSR IMPACTS WHAT WE INCLUDE IN APPLICATIONS LOOK TO THE END, AT THE BEGINNING 36

EX. 3 - PROSECUTION DRAMATIC IMPACT OF KSR ON PROSECUTION, IN A REEXAMINATION 37

CLIENT CONFIDENCES I AM NOT OF RECORD REEXAM NUMBER NOT SPECIFIED FACTS DE-IDENTIFIED 38

SUMMARY PRE KSR ALLOWANCE POST KSR REJECTION, BASED UPON KSR ON SAME PRIOR ART 39

PROSECUTION HISTORY LETS FOLLOW THE PROSECUTION HISTORY IN SOME DETAIL 40

PRE KSR 1 ST OA REJECT ALL CLAIMS AS OBVIOUS BASED UPON REFERENCES A, B, AND C A IS THE CLOSEST PRIOR ART 41

PRE KSR 1 ST OA REJECTIONS BASED UPON MODIFICATIONS OF A IN VIEW OF B AND C TO CHANGE LIMITATIONS X1 TO X2 42

TACTICS MAKE ONLY THOSE ARGUMENTS NECESSARY TO OVERCOME REJECTIONS AVOID ESTOPPELS 43

TACTICS POSSIBLE RESPONSES NO LEGAL MOTIVATION TO MODIFY CLAIMS DO NOT READ ON THE PROPOSED MODIFICATION 44

RESPONSE TO 1 ST OA NO LEGAL MOTIVATION TO MODIFY PRIOR ART DOES NOT SUGGEST MODIFICATION OF X1 TO X2 45

BENEFIT OF RESPONSE RESPONSE DID NOT REQUIRE A DETAILED ANALYSIS CONSTRUING CLAIMS VIZ ELEMENTS TAUGHT BY PRIOR ART REFS. 46

2 ND,FINAL, OA ALLOWED ALL CLAIMS OVER PRIOR ART REJECTED SOME DEPENDENT CLAIMS UNDER 112 47

RESPONSE TO 2 ND, FINAL, OA PATENTEE AMENDED DEPENDENT CLAIMS, CURING THE 112 PROBLEMS SHOULD HAVE RESULTED IN ALLOWANCE 48

KSR KSR OPINION ISSUED AFTER RESPONSE TO 2 nd, FINAL, OA. 49

POST KSR 3 RD, NON - FINAL, OA REJECTS ALL CLAIMS BASED UPON REFS. A, B, AND C 50

WHY NON-FINAL? PROCEDURALLY, N0N-FINAL OA, AFTER A FINAL OA, MEANS NEW REJECTIONS NOT DUE TO APPLICANTS AMENDMENTS 51

POST KSR 3 RD, NON - FINAL, OA RELIED UPON A TO SUGGEST REPLACING X1 WITH X2 RELIED UPON B, C, TO SHOW ENABLEMENT OF X2 52

REF. A NO SUGGESTION IN A TO MODIFY A EMBODIMENT TO INCLUDE LIMITATIONS X2 MODIFYING A TO INCLUDE LIMITATIONS X2 REMOVES UTILITY SPECIFIED IN A CONLUSION A TEACHES AWAY FROM X2 MODIFICATION 53

REF. A A SUGGESTED USE Y X1 EMBODIMENT CAN PROVIDE USE Y MODIFICATION OF A REPLACING X1 WITH X2 COULD ALSO PERFORM USE, Y, BUT IN A DIFFERENT WAY 54

EXAMINER S POST KSR REASONING Not be reasonable to consider from [A] that [USE Y] is tied solely to [X1] one of ordinary skill in the art, having... [DESIGN SKILLS], would readily recognize, through the exercise of common sense, what... [things] are not required or what... [things] would need to be modified. 55

KSR OVER REACTION EXAMINER - Not be reasonable to consider from [A] that [USE Y] is tied solely to [X1] THAT REASONING IS NOT BASED UPON EVIDENCE OF RECORD; - - OVER REACTION TO KSR 56

KSR RELIANCE EXAMINER - would readily recognize, through the exercise of common sense... LANGAUGE PARALLELS THAT IN KSR 57

KSR QUOTE When there is a design need or market pressure to solve a problem and there are a finite number of identified, predictable solutions, a person of ordinary skill has good reason to pursue the known options within his or her technical grasp. If this leads to the anticipated success, it is likely the product not of innovation but of ordinary skill and common sense. In that instance the fact that a combination was obvious to try might show that it was obvious under 103. 58

PATENTEE S NEW RESPONSE PRIMARILY, DETAILED CLAIM CONSTRUCTION SHOWING PRIOR ART LACKS CERTAIN CLAIMED FEATURES SECONDARILY, NO MOTIVATION TO MODIFY, AND OVER REACTION TO KSR 59

CONCLUSIONS MY ANECDOTES SHOW THAT KSR HAS SUBSTANTIALLY IMPACTED PATENT PROSECUTION, ADVICE, AND COUNSELING 60

THE END THANK YOU! RICHARD NEIFELD, PH.D., PATENT ATTY. NEIFELD IP LAW, PC - www.neifeld.com StockPricePredictor.com, LLC - www.patentvaluepredictor.com EMAIL: rneifeld@neifeld.com TEL: 703-415-0012 EXT. 21 61